COVID caused industry leaders to pivot in new directions of operation, some of which allow businesses to survive and even thrive in the new landscape. In the healthcare field there is research to support the assertion that a technologically driven, patient-centric route will allow leaders to succeed in the ‘new normal’.
To understand the impact and aftereffects of COVID on healthcare organizations and how the front office (particularly the sales organization) in Life Sciences companies must retool for this “new normal,” the KPMG Sales Transformation team conducted a pulse survey of almost 100 providers including surgeons, primary care, and hospital C-suite members. Learn more about this survey’s findings here.
This webcast incorporates survey findings and provides strategic recommendations to consider technology investments and how to maximize selling opportunities for the future.